Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bio-Works Technologies AB | 2,178,184 | net | 25 May 2022 | tx 2+2,178,184 |
| Enad Global 7 AB (publ) | 2,129,159 | net | 07 May 2026 | tx 15+2,129,159 |
| Eros Capital Partners AB | 661,848 | net | 19 Feb 2026 | tx 3+661,848 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | PURCHASE | Enad Global 7 AB (publ) | 34,804 | 18.85 SEK | |
| 20 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 14,669 | 14.65 SEK | |
| 23 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 18,630 | 14.64 SEK | |
| 24 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 5,212 | 14.65 SEK | |
| 25 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 8,044 | 14.97 SEK | |
| 06 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 179,200 | 15.00 SEK | |
| 09 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 12,165 | 14.95 SEK | |
| 09 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 150,500 | 15.00 SEK | |
| 10 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 72,674 | 15.83 SEK | |
| 11 Mar 2026 | PURCHASE | Enad Global 7 AB (publ) | 285,887 | 15.98 SEK | |
| 24 Feb 2026 | PURCHASE | Enad Global 7 AB (publ) | 355,409 | 15.32 SEK | |
| 24 Feb 2026 | PURCHASE | Enad Global 7 AB (publ) | 140,000 | 15.72 SEK | |
| 25 Feb 2026 | PURCHASE | Enad Global 7 AB (publ) | 25,678 | 15.99 SEK | |
| 18 Feb 2026 | PURCHASE | Eros Capital Partners AB | 72,401 | 15.27 SEK | |
| 17 Feb 2026 | PURCHASE | Eros Capital Partners AB | 459,667 | 13.17 SEK | |
| 19 Feb 2026 | PURCHASE | Eros Capital Partners AB | 129,780 | 15.68 SEK | |
| 12 Nov 2025 | PURCHASE | Enad Global 7 AB (publ) | 250,000 | 13.17 SEK | first after silence |
| 17 Feb 2023 | PURCHASE | Enad Global 7 AB (publ) | 576,287 | 27.20 SEK | |
| 25 May 2022 | PURCHASE | Bio-Works Technologies AB | 1,089,092 | 16.25 SEK |
1 purchase reported after at least 12 months of silence — most recent on 12 Nov 2025.